Merck, BMS Target Hetero Over Generic HIV Drug Sustiva
Merck Sharp & Dohme Corp. and Bristol-Myers Squibb Co. fired off patent infringement allegations in New Jersey federal court Thursday over Hetero Labs Ltd.'s plans to make a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article